Department of Justice, DEA propose cuts to opioid production
WASHINGTON - The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction in opioid production in the next year.
The agencies are looking to align with President Trump's "Safe Prescribing Plan", which seeks to cut nationwide opioid prescription fills by one-third within three years. A release from the DOJ claims the proposal decreases manufacturing quotas for the six most frequently misused opioids for 2019 by an average of ten percent as compared to the 2018 amount.
This marks the third straight year of proposed reductions.
The DEA has proposed to reduce more commonly prescribed schedule II opioids, including oxycodone, hydrocodone, oxymorphone, hydromorphone, morphine, and fentanyl.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
I-10 westbound near Grosse Tete closed Saturday night
Loved ones honor victim of domestic violence at Southern homecoming tailgate
FDA OKs mixing COVID vaccines; backs Moderna, J&J boosters
'Pedal Pub' party bikes coming to downtown Baton Rouge
Companion Animal Alliance working to find solution to shelter overflow